The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ctDNA resistance landscape of lazertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI).
 
Ji-Youn Han
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Takeda
Research Funding - Ono Pharmaceutical; Pfizer; Roche; Takeda
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Lilly; MSD; TAKEDA
Consulting or Advisory Role - Alpha pharmaceutical; AstraZeneca; Boehringer Ingelheim; Lilly; MSD; TAKEDA
 
Sang-We Kim
No Relationships to Disclose
 
Ki Hyeong Lee
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD
 
Eun Kyung Cho
No Relationships to Disclose
 
Yun-Gyoo Lee
No Relationships to Disclose
 
Dong-Wan Kim
Research Funding - Alpha Biopharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Hanmi (Inst); Janssen (Inst); Merus (Inst); Mirati Therapeutics (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst); TP Therapeutics (Inst); Xcovery (Inst); Yuhan (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo
 
Joo-Hang Kim
No Relationships to Disclose
 
Jong-Seok Lee
No Relationships to Disclose
 
Gyeong-Won Lee
No Relationships to Disclose
 
Byoung Yong Shim
No Relationships to Disclose
 
Jin-Soo Kim
Stock and Other Ownership Interests - Chong Kun Dang Pharmaceutical; DAEHWA Pharmaceutical
Honoraria - AstraZeneca; Boehringer Ingelheim; CJ Healthcare; DAEHWA Pharmaceutical; Lilly; Merck
Consulting or Advisory Role - CJ Healthcare; Lilly
Research Funding - Alpha Biopharma; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Chong Kun Dang Pharmaceutical; CJ Healthcare; Hanmi; IL-Yang Pharm; Lilly; Merck; MSD; Novotech; Ono Pharmaceutical; Pfizer; Sanofi; Yuhan
Expert Testimony - CJ Healthcare
 
Sang Hoon Chun
No Relationships to Disclose
 
Sung Sook Lee
No Relationships to Disclose
 
Young Joo Min
No Relationships to Disclose
 
Sang Won Shin
No Relationships to Disclose
 
Arielle Yablonovitch
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Carin R. Espenschied
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Hyunwoo Jang
Employment - Yuhan
 
Byoung Chul Cho
Stock and Other Ownership Interests - Bridgebio; Gencurix; Theravance
Honoraria - AstraZeneca; Bayer; Champions Oncology; Dizal Pharma; Dong-A ST; Janssen; Mogam Biotechnology Research Institue; MSD; Novartis; Ono Pharmaceutical; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda; Yuhan
Speakers' Bureau - Novartis
Research Funding - AstraZeneca; Bayer; Champions Oncology; Dizal Pharma; Dong-A ST; Janssen; Mogam Biotechnology Research Institue; MSD; Novartis; Ono Pharmaceutical; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology